Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-17 · accession 0001140361-24-049939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2024-12-19 | 2024-12-17+ | GYRE | Ma Songjiang | Pres, Dir | S - Sale | $11.21 | -4,000 | 2.94M | -0.1% | -$44.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | S | D | 788 | $11.23 | 2,940,467 | I By Spouse | — | — | (F3) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.10 to $11.37. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-12-18 | S | D | 1,571 | $11.17 | 2,938,896 | I By Spouse | — | — | (F4) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.70 to $11.69. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-17 | S | D | 1,212 | $10.94 | 2,941,255 | I By Spouse | — | — | (F2) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.10 to $11.095. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-12-18 | S | D | 429 | $12.11 | 2,938,467 | I By Spouse | — | — | (F5) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.70 to $12.46. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |